Twelve weeks treatment with the DPP-4 inhibitor, sitagliptin, prevents degradation of peptide YY and improves glucose and non-glucose induced insulin secretion in patients with type 2 diabetes mellitus

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Twelve weeks treatment with the DPP-4 inhibitor, sitagliptin, prevents degradation of peptide YY and improves glucose and non-glucose induced insulin secretion in patients with type 2 diabetes mellitus. / Aaboe, K; Knop, F K; Vilsbøll, T; Deacon, C F; Holst, Jens Juul; Madsbad, S; Krarup, Troels Magelund.

In: Diabetes, Obesity and Metabolism, Vol. 12, No. 4, 01.04.2010, p. 323-33.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Aaboe, K, Knop, FK, Vilsbøll, T, Deacon, CF, Holst, JJ, Madsbad, S & Krarup, TM 2010, 'Twelve weeks treatment with the DPP-4 inhibitor, sitagliptin, prevents degradation of peptide YY and improves glucose and non-glucose induced insulin secretion in patients with type 2 diabetes mellitus', Diabetes, Obesity and Metabolism, vol. 12, no. 4, pp. 323-33. https://doi.org/10.1111/j.1463-1326.2009.01167.x

APA

Aaboe, K., Knop, F. K., Vilsbøll, T., Deacon, C. F., Holst, J. J., Madsbad, S., & Krarup, T. M. (2010). Twelve weeks treatment with the DPP-4 inhibitor, sitagliptin, prevents degradation of peptide YY and improves glucose and non-glucose induced insulin secretion in patients with type 2 diabetes mellitus. Diabetes, Obesity and Metabolism, 12(4), 323-33. https://doi.org/10.1111/j.1463-1326.2009.01167.x

Vancouver

Aaboe K, Knop FK, Vilsbøll T, Deacon CF, Holst JJ, Madsbad S et al. Twelve weeks treatment with the DPP-4 inhibitor, sitagliptin, prevents degradation of peptide YY and improves glucose and non-glucose induced insulin secretion in patients with type 2 diabetes mellitus. Diabetes, Obesity and Metabolism. 2010 Apr 1;12(4):323-33. https://doi.org/10.1111/j.1463-1326.2009.01167.x

Author

Aaboe, K ; Knop, F K ; Vilsbøll, T ; Deacon, C F ; Holst, Jens Juul ; Madsbad, S ; Krarup, Troels Magelund. / Twelve weeks treatment with the DPP-4 inhibitor, sitagliptin, prevents degradation of peptide YY and improves glucose and non-glucose induced insulin secretion in patients with type 2 diabetes mellitus. In: Diabetes, Obesity and Metabolism. 2010 ; Vol. 12, No. 4. pp. 323-33.

Bibtex

@article{236421d49c5c444c96f5947d5039b8a4,
title = "Twelve weeks treatment with the DPP-4 inhibitor, sitagliptin, prevents degradation of peptide YY and improves glucose and non-glucose induced insulin secretion in patients with type 2 diabetes mellitus",
abstract = "To examine the effects of 12 weeks of treatment with the DPP-4 inhibitor, sitagliptin, on gastrointestinal hormone responses to a standardized mixed meal and beta cell secretory capacity, measured as glucose and non-glucose induced insulin secretion during a hyperglycaemic clamp, in patients with type 2 diabetes.",
keywords = "Adult, Aged, Diabetes Mellitus, Type 2, Dipeptidyl-Peptidase IV Inhibitors, Double-Blind Method, Drug Administration Schedule, Female, Gastric Inhibitory Polypeptide, Glucagon-Like Peptide 1, Glucagon-Like Peptide 2, Humans, Hypoglycemic Agents, Insulin, Male, Metformin, Middle Aged, Peptide YY, Postprandial Period, Pyrazines, Triazoles",
author = "K Aaboe and Knop, {F K} and T Vilsb{\o}ll and Deacon, {C F} and Holst, {Jens Juul} and S Madsbad and Krarup, {Troels Magelund}",
year = "2010",
month = "4",
day = "1",
doi = "10.1111/j.1463-1326.2009.01167.x",
language = "English",
volume = "12",
pages = "323--33",
journal = "Diabetes, Obesity and Metabolism",
issn = "1462-8902",
publisher = "Wiley-Blackwell",
number = "4",

}

RIS

TY - JOUR

T1 - Twelve weeks treatment with the DPP-4 inhibitor, sitagliptin, prevents degradation of peptide YY and improves glucose and non-glucose induced insulin secretion in patients with type 2 diabetes mellitus

AU - Aaboe, K

AU - Knop, F K

AU - Vilsbøll, T

AU - Deacon, C F

AU - Holst, Jens Juul

AU - Madsbad, S

AU - Krarup, Troels Magelund

PY - 2010/4/1

Y1 - 2010/4/1

N2 - To examine the effects of 12 weeks of treatment with the DPP-4 inhibitor, sitagliptin, on gastrointestinal hormone responses to a standardized mixed meal and beta cell secretory capacity, measured as glucose and non-glucose induced insulin secretion during a hyperglycaemic clamp, in patients with type 2 diabetes.

AB - To examine the effects of 12 weeks of treatment with the DPP-4 inhibitor, sitagliptin, on gastrointestinal hormone responses to a standardized mixed meal and beta cell secretory capacity, measured as glucose and non-glucose induced insulin secretion during a hyperglycaemic clamp, in patients with type 2 diabetes.

KW - Adult

KW - Aged

KW - Diabetes Mellitus, Type 2

KW - Dipeptidyl-Peptidase IV Inhibitors

KW - Double-Blind Method

KW - Drug Administration Schedule

KW - Female

KW - Gastric Inhibitory Polypeptide

KW - Glucagon-Like Peptide 1

KW - Glucagon-Like Peptide 2

KW - Humans

KW - Hypoglycemic Agents

KW - Insulin

KW - Male

KW - Metformin

KW - Middle Aged

KW - Peptide YY

KW - Postprandial Period

KW - Pyrazines

KW - Triazoles

U2 - 10.1111/j.1463-1326.2009.01167.x

DO - 10.1111/j.1463-1326.2009.01167.x

M3 - Journal article

C2 - 20380653

VL - 12

SP - 323

EP - 333

JO - Diabetes, Obesity and Metabolism

JF - Diabetes, Obesity and Metabolism

SN - 1462-8902

IS - 4

ER -

ID: 33939951